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The incidence of type 1 diabetes (T1D) shows a worrying tendency for a steady increase in Western
countries.Along thelineofthe hygienehypothesis,evidenceaccumulatestosuggestthatthisincreaseis
explainedbythedecreaseofinfectionsduetoimprovedhygieneandmedicalcare.Thisarticlepresentsa
review of epidemiological data and of the main putative underlying cellular and molecular mechanisms.
EPIDEMIOLOGY
The steady rise in the incidence of T1D in developed
countries over the last three decades is a matter of major
public health concern (Gale, 2002). Taken together with a
very uneven distribution of the disease worldwide, with a
North–Southgradient,thisincreaseinincidenceprompted
epidemiologiststodeterminethefactorsthatcouldpossibly
explain this unfortunate trend. The fact that similar
epidemiological features have been observed for other
autoimmune diseases, notably multiple sclerosis, and for
allergic diseases (Bach, 2002), suggests that the expla-
nation is probably not essentially speciﬁc to T1D. There is
epidemiologicalevidenceforthecausalroleofthedecrease
of infections in the increase of incidence of T1D.
The negative relationship observed between the decline
in the incidence of major infectious diseases and increase
in T1D is suggestive but not by any means demonstrative
of a causal relationship. Similarly, the uneven geographi-
cal distribution of the disease shows interesting but only
very indirect evidence in this direction, even though the
increased T1D incidence in children in families having
migrated from low-incidence to high-incidence countries
(Bodansky et al., 1992) is highly suggestive. Clearly
northern countries have a higher socio-economic level
than southern countries as is illustrated by the positive
correlation observed between T1D incidence and gross
national product in Europe (Bach, 2002). However, other
factors differ among these various countries, such as
climate and diet.
CAUSAL RELATIONSHIP
Two sets of data, however, incriminate infections or more
generally the infectious environment (sanitary quality of
water and food, conditions of lodging). First, in studies in
well-circumscribed regions such as Northern Ireland, a
positive correlation was observed between socio-econo-
mic indices and T1D incidence with a particular
implication of household crowding (Patterson et al.,
1996). Secondly, it is striking to note that T1D is more
common in ﬁrst-born children of families at risk for T1D,
suggesting that for a given genetic inheritance, the
exposure of children to infections brought by siblings may
be protective (Deschamps et al., 1986).
Other pieces of evidence for a causal relationship
are derived from immune disorders other than T1D.
The increased risk of atopic diseases in children
systematically treated with antihelminthic agents (in an
infected region) (Lynch et al., 1993) or after vacci-
nation against Streptococcus pneumoniae (Klugman
et al., 2003) is highly suggestive as well as protection
from atopy afforded by administration or probiotics
(Kalliomaki et al., 2001).
In fact, the best evidence for a causal relationship is
derived from animal models. Both the non-obese diabetic
(NOD) mouse and the Bio-Breeding (BB) rat show T1D
with a much higher incidence when they are bred in
speciﬁc pathogen-free (SPF) than in conventional
conditions (Bach, 2002). It is sufﬁcient to decontaminate
the mice bred in the latter type of environment to observe
increased incidence, as has been well-demonstrated for
NOD mice (Bach, 2002).
Even more striking is the prevention of T1D observed in
NOD mice and to a lesser extent in BB rats by infection
with various pathogens. The ﬁrst demonstration of this
protective effect in the context of T1D was the observation
that administration of complete Freund’s adjuvant
to young NOD mice prevents diabetes onset (Sadelain
et al., 1990). NOD mice do not develop T1D when they
are infected at an early age by bacteria such as
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Mycobacterium avium (Bras and Aguas, 1996), viruses
such as lymphochoriomeningitis virus (Oldstone, 1990),
lactodehydrogenase virus (Takei et al., 1992) or murine
hepatitis virus (Wilberz et al., 1991), or parasites (such as
schistosomes) (Cooke et al., 1999).
It is interesting to note that the pathogen does not
necessarily need to be alive to afford protection, as
illustrated by the protective effect of bacterial extracts
(streptococci, Toyota et al., 1986; klebsiella, Sai and
Rivereau, 1996 or Escherichia coli, our unpublished data).
MECHANISMS
Animal models offer a remarkable way to dissect the
mechanisms explaining the protective effect of infections
on T1D.
Homeostatic Competition
It had been known for several decades that successive
administration of two unrelated antigens led to major
interferencewith decreased response to the second antigen
(Liacopoulos and Ben-Efraim, 1975). The mechanisms of
antigenic competition are still ill-deﬁned. They may
involve competition for macrophage antigen uptaking or
processing, notably for the binding of peptides to MHC
molecules as has been described in some models.
Another approach to antigen competition is derived
from the improved understanding of lymphocyte homeo-
stasis. It had been known for a long time that lymphocyte
depletion, as may be induced for example by administe-
ring large doses of glucocorticoids, is rapidly corrected
independently by seeding of newly formed lymphocytes
from the thymus. It has recently been realized that this
lymphocyte expansion was driven by various signals
including TCR-mediated recognition of self-peptides in
the context of MHC molecules and various cytokines
including IL-7 (Jameson, 2002).
The control of T cells involved in the pathogenesis of
immune disorders by homeostatic mechanisms was
suspected because of the common occurrence of
autoimmune diseases in lymphopenic animals; whether
lymphopenia is genetically determined in the case of BB
rats (Poussier et al., 1982), or experimentally induced as
in the case of autoimmune states induced by thymectomy
(Asano et al., 1996) and/or sublethal irradiation (Fowell
and Mason, 1993). It was thus particularly interesting to
see that prevention of colitis developing in lymphopenic
SCID mice reconstituted by CD4 T cells depleted from the
regulatory subset of CD45RB
low T cells is inhibited by
expansion in the recipient mice of a T cell clone speciﬁc to
an unrelated antigen (Barthlott et al., 2003). Such
inhibition of colitis development is most likely explained
by competition for homeostatic signals between effector
cells inducing colitis and unrelated rapidly proliferating
lymphocytes. One may hypothesize that the lymphocyte
expansion associated with an anti-infectious response
could be at the origin of a similar competition. This is
illustrated by the recent observation that administration of
complete Freund’s adjuvant in NOD mice is associated
with a decreased proliferation of lymphocytes in response
to homeostatic signals (King et al., 2004).
Bystander Suppression
Immune responses to infectious agents give rise to the
generation of regulatory T cells like other immune
responses. The suppression exerted by these regulatory
T cells (which is speciﬁcally induced by the antigens of
the pathogen) is likely to extend to other immune
responses, according to the well-established phenomenon
of bystander suppression mediated by regulatory cyto-
kines such as IL-10 and TGFb (Fowell and Mason, 1993).
Evidence in this direction derivesfrom studies indicating a
role for these cytokines in the protective effect of
infections in T1D. It has thus been reported that the
diabetes protection afforded by CFA in NOD mice is
abrogated by combined administration of anti-IL-4 and
anti-IL-10 antibodies (Shehadeh et al., 1993). This
observation must, however, be interpreted with caution
since CFA still protects NOD IL-4
2/2 and NOD IL-10
2/2
NOD mice from diabetes (whereas it does not in IFNg
2/2
NOD mice) (Serreze et al., 2001). In our laboratory, we
observed that the protective effect of an E. Coli extract
was abrogated by administration of a neutralizing anti-
TGFb antibody (in preparation). As far as NKT cells are
concerned, one may mention here recent studies showing
increased IL-10 production and NKT cell production in
NOD mice protected from T1D by infestation with
schistosomes (Zaccone et al., 2003).
NON-ANTIGEN RELATED SUPPRESSION.
THE ROLE OF TOLL-LIKE RECEPTOR (TLR)
STIMULATION
Infectious agents may also downregulate immune
responses through mechanisms which do not involve the
induction of an immune response against their antigenic
constituents. The ﬁrst mechanism to be considered in this
context is that of TLR stimulation. One might assume
that TLR stimulation essentially leads to the production
of pro-inﬂammatory cytokines that could be expected to
accelerate T1D progression. In fact, this is not what
was observed with various TLR agonists. T1D onset is
prevented in NOD mice by LPS and TLR4 agonists
(Tian et al., 2001), and by CpG, a TLR9 agonist (Quintana
et al., 2000). These observations are similar to those
made in experimental colitis, where the protective effect
of probiotics is not observed in TLR 9
2/2 mice
(Rachmilewitz et al., 2004).
Other mechanisms could be proposed as suggested by
recent data obtained for the hepatitis A virus (which
stimulates Th2 cells expressing the HAV receptor)
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measles virus protein (Marie et al., 2001) and by various
parasites (Mazingue et al., 1986).
WHY DO INFECTIONS STIMULATE OR
PROTECT FROM AUTOIMMUNITY?
There is well-documented evidence showing that infec-
tions may induce autoimmune diseases either through
cross-reactivity with autoantigens (as in the case of
rheumatic fever or Guillain-Barre ´ syndrome) or by local
inﬂammation (as in the case of Theiler’s disease).
There are still limited data in T1D for these two
hypotheses even if epidemiological data have been
reported in favor of certain viruses, particularly entero-
viruses (notably Coxsackie B4) (Jun and Yoon, 2003).
Perhaps the long lag time spent between the triggering
infection and T1D clinical onset renders the ﬁnding of a
clearer picture difﬁcult.
In any case, the mechanisms leading to autoimmune
disease induction (antigen mimicry or inﬂammation)
and to protection (homeostatic competition, bystander
suppression, TLR stimulation) are very different and
not mutually exclusive. One may hypothesize that
autoimmune diseases such as T1D may be triggered
(or exacerbated) by speciﬁc pathogens, whether the
speciﬁcity is due to epitopes cross reactive with b cell-
speciﬁc autoantigens or to the organ tropism of the
infectious agent (as in the case of Cocksackie B4 for the
pancreas). Conversely, one may assume that the protective
effect of infections is essentially non-speciﬁc in terms of
the target organ of the autoimmune disease.
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